Food Allergy Market to Witness Remarkable Growth, Key Insights, and Global Outlook Revealed in New 2031 Forecast Report
06 févr. 2024 10h06 HE
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Food Allergy Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to...
Intrommune Therapeutics To Present A New Form Of Allergy Treatment At The 2024 American Academy Of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
06 févr. 2024 09h34 HE
|
Intrommune Therapeutics
New study is the first to evaluate Oral Mucosal Immunotherapy (OMIT) for the treatment of food allergy
UPDATE Latitude Food Allergy Care Announces the Opening of its Second New York City Location; Brooklyn Heights Clinic Will Provide Exceptional Food Allergy Care
01 févr. 2024 10h01 HE
|
Latitude Food Allergy Care
Redwood City, CA and New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Latitude Food Allergy Care, the leading network of clinics providing life-changing testing and treatment, including oral...
Astonish Media Group Announces Latitude Food Allergy Care Joins its Prestigious Portfolio of Clients
17 janv. 2024 12h40 HE
|
Astonish Media Group
NewYork, NY, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Astonish Media Group, a leading boutique public relations and media strategy firm based in New York City, announces the addition of Latitude Food...
Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy for the treatment of peanut allergy
08 janv. 2024 09h05 HE
|
Intrommune Therapeutics
Inimmune Corporation and Intrommune Therapeutics announce a collaboration to advance a revolutionary rapid, long-acting oral mucosal allergy immunotherapy
US Food Allergen Testing Market Outlook to 2028 - New York Commands Attention in the Eastern Region with Innovative Allergens Detection Technology
14 déc. 2023 11h08 HE
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "US Food Allergen Testing Market Outlook to 2028" report has been added to ResearchAndMarkets.com's offering. With the increasing prevalence of food...
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment of Peanut Allergy
09 nov. 2023 11h01 HE
|
Intrommune Therapeutics
Intrommune Therapeutics Presents Positive Results of Phase 1 OMEGA Study Investigating the Safety of INT301 Toothpaste for the Treatment Peanut Allergy
Pet Allergy Treatment Industry Analysis: Anticipated Market to Reach a Size of US$ 4.1 Billion by 2033, Persistence Market Research
24 août 2023 08h54 HE
|
Persistence Market Research
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The global pet allergy treatment market reached a size of US$ 2.1 billion in 2022 and is forecasted to expand at a CAGR of 6.3% from 2023 to 2033,...
The Difference Baker Partners With George Mason University and Sodexo to Create the First True Allergy-Friendly Dining Experience on a U.S. College Campus
09 août 2023 15h46 HE
|
The Difference Baker
ASHBURN, Va., Aug. 09, 2023 (GLOBE NEWSWIRE) -- The Difference Baker is thrilled to announce a historic collaboration with George Mason University (GMU) and Sodexo, establishing the first retail...
Intrommune Therapeutics Completes Last Patient Last Visit in the Phase 1 OMEGA Study for Peanut Allergy
25 juil. 2023 09h35 HE
|
Intrommune Therapeutics
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food...